Back

Diagnostics: the growing arsenal of cardiac biomarkers: soluble neprilysin.

23 May 2016 (16:30 - 16:43)
Organised by:
Congress Presentation Part of: What's new in Industry? Miscellaneous HFA Premium Access HEART FAILURE 2016

9 More presentations in this session

Presentation thumbnail
Discussion.
Presentation thumbnail
Medtronic International: CRT response optimisation with novel, non-invasive diagnostic technology.
Slides Video
Presentation thumbnail
Discussion.
Presentation thumbnail
Abbott Vascular: present & future of Abbott Vascular research in structural heart diseases.
Slides Video
Presentation thumbnail
Discussion.

Access the full session

Session thumbnail
What's new in Industry?

The Event

Event poster

HEART FAILURE 2016

23 May 2016 16:30 CET
You may be interested in
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
The source of liberation of dipeptidyl peptidase 3 (DPP3), a newly emerged cardiac biomarker, in pathological situations
20 May 2023
thumbnail
Congress Presentation
Effect of neprilysin inhibition on blood urea nitrogen creatinine ratio in HFrEF : comparison of the solvd and paradigm-hf trials
21 May 2023
thumbnail
Congress Presentation
NT-proBNP and high-sensitivity cardiac troponin T to diagnose cardiac amyloidosis
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources